VJVirtual

GoCART Coalition: collaboration across stakeholders 2:50
GoCART Coalition: collaboration across stakeholders
Sofie Terwel • 28 Jan 2021
Collaboration in the field of cellular therapies 1:48
Collaboration in the field of cellular therapies
Sofie Terwel • 28 Jan 2021
Current activities of GoCART 1:41
Current activities of GoCART
Sofie Terwel • 28 Jan 2021
CART19-BE-01: ARI-0001 in CD19+ malignancies 8:17
CART19-BE-01: ARI-0001 in CD19+ malignancies
Valentín Ortiz-Maldonado • 11 Oct 2020
Immunotherapy for T-cell malignancies 7:38
Immunotherapy for T-cell malignancies
John DiPersio
Next questions in CAR-based therapies 3:56
Next questions in CAR-based therapies
John DiPersio
Adaptimmune: SPEAR T-cells 6:02
Adaptimmune: SPEAR T-cells
Helen Tayton-Martin • 15 Oct 2020
T-cells: challenges in bringing to market 4:21
T-cells: challenges in bringing to market
Helen Tayton-Martin • 15 Oct 2020
The cell therapy landscape: disruptive technologies 3:12
The cell therapy landscape: disruptive technologies
Helen Tayton-Martin • 15 Oct 2020
The potential of RegenMed in the oncology space 1:41
The potential of RegenMed in the oncology space
Helen Tayton-Martin • 15 Oct 2020
Progress in the face of COVID-19 1:37
Progress in the face of COVID-19
Janet Lambert • 5 Oct 2020
Meeting on the Mesa 2020 goes virtual 1:39
Meeting on the Mesa 2020 goes virtual
Janet Lambert • 5 Oct 2020
Key themes and discussions at Meeting on the Mesa 2020 1:49
Key themes and discussions at Meeting on the Mesa 2020
Janet Lambert • 5 Oct 2020
Introducing ARM: The Alliance for Regenerative Medicine 1:01
Introducing ARM: The Alliance for Regenerative Medicine
Janet Lambert • 5 Oct 2020
Challenges facing the regenmed sector in 2020 2:12
Challenges facing the regenmed sector in 2020
Janet Lambert • 5 Oct 2020
Putting the patient first in regenerative medicine 2:32
Putting the patient first in regenerative medicine
Paige Bischoff • 6 Oct 2020
The content of VJRegenMed is intended for healthcare professionals